Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 5/20 | 0.55 |
| ▸ | PLA2G4A | P47712 | 5/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | NPC1 | O15118 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.49 |
| ▸ | AHR | P35869 | 2/20 | 0.47 |
| ▸ | GABRP | O00591 | 1/20 | 0.43 |
| ▸ | GABRD | O14764 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | TNKS | O95271 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9889861 | 0.94 | PLA2G2A (0.53) | PLA2G2APLA2G4AMAPTHPGDNPC1 | |
| SCHEMBL26820304 | 0.94 | PLA2G2A (0.60) | PLA2G2APLA2G4AMAPTHPGDNPC1 | |
| SCHEMBL30257612 | 0.94 | PLA2G2A (0.60) | PLA2G2APLA2G4AMAPTHPGDNPC1 | |
| SCHEMBL18697934 | 0.94 | PLA2G2A (0.60) | PLA2G2APLA2G4AMAPTHPGDNPC1 | |
| SCHEMBL30525788 | 0.94 | PLA2G2A (0.60) | PLA2G2APLA2G4AMAPTHPGDNPC1 | |
| SCHEMBL13991440 | 0.94 | PLA2G2A (0.60) | PLA2G2APLA2G4AMAPTHPGDNPC1 | |
| SCHEMBL20277362 | 0.94 | PLA2G2A (0.60) | PLA2G2APLA2G4AMAPTHPGDNPC1 | |
| SCHEMBL26820311 | 0.94 | PLA2G2A (0.60) | PLA2G2APLA2G4AMAPTHPGDNPC1 | |
| SCHEMBL20706686 | 0.94 | PLA2G2A (0.60) | PLA2G2APLA2G4AMAPTHPGDNPC1 | |
| SCHEMBL9889838 | 0.92 | PLA2G2A (0.55) | PLA2G2APLA2G4AMAPTKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9799835-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2017-10-24 | — | — | US | disclosed |
| US-9799835-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2017-10-24 | — | — | US | disclosed |
| US-20160020410-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2016-01-21 | — | — | US | disclosed |
| US-20160020410-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2016-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160020410-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | OR51E2, NFE2L2, ORAI2 | PLA2G2A 3809/4885PLA2G4A 3453/4885MAPT 1366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.